Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

OBJECTIVES The Xq28 region, containing IRAK and MECP2, represent a common susceptibility locus for a high number of autoimmune diseases. Our aim in the present study was to evaluate the influence of the IRAK1 and MECP2 autoimmunity-associated genetic variants in the giant cell arteritis (GCA) susceptibility and its clinical subphenotypes. METHODS We analysed a total of 627 female biopsy-proven GCA patients and 1,520 female healthy controls of Spanish Caucasian origin. Two polymorphisms, rs1059702 and rs17345, located at IRAK1 and MECP2, respectively, were genotyped using TaqMan® allelic discrimination assays. RESULTS No association with any of the analysed polymorphisms was evident when genotype and allele frequencies were compared between GCA patients and controls (rs1059702: allelic p-value=0.699, OR=0.96, CI 95% 0.80-1.17; rs17435: allelic p-value=0.994, OR=1.00, CI 95% 0.84-1.19). Likewise, the subphenotype analysis yield similar negative results. CONCLUSIONS We have assessed for the first time the possible role of IRAK1 and MECP2 autoimmune disease-associated polymorphisms in GCA. Our data suggest that IRAK1 rs1059702 and MECP2 rs17435 genetic variants do not play a significant role in GCA susceptibility or severity.

[1]  R. Madhok,et al.  New insight on the Xq28 association with systemic sclerosis , 2013, Annals of the rheumatic diseases.

[2]  Eli Stahl,et al.  High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis , 2012, Nature Genetics.

[3]  R. Cantor,et al.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups , 2012, Annals of the rheumatic diseases.

[4]  G. Hunder,et al.  Clinical features of polymyalgia rheumatica and giant cell arteritis , 2012, Nature Reviews Rheumatology.

[5]  Javier Martín,et al.  Evaluation of a Shared Autoimmune Disease-associated Polymorphism of TRAF6 in Systemic Sclerosis and Giant Cell Arteritis , 2012, The Journal of Rheumatology.

[6]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[7]  L. Mouthon,et al.  Pathogenesis of giant cell arteritis: More than just an inflammatory condition? , 2010, Autoimmunity reviews.

[8]  R. Jonsson,et al.  Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome , 2010, Annals of the rheumatic diseases.

[9]  Javier Martín,et al.  Epidemiology of giant cell arteritis and polymyalgia rheumatica. , 2009, Arthritis and rheumatism.

[10]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[11]  Michael U. Martin,et al.  Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. , 2002, Biochimica et biophysica acta.

[12]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[13]  Javier Martín,et al.  Genetic component of giant cell arteritis. , 2014, Rheumatology.

[14]  S. Bombardieri,et al.  Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients. , 2013, Clinical and experimental rheumatology.

[15]  S. Bombardieri,et al.  Systemic vasculitis: a critical digest of the recent literature. , 2013, Clinical and experimental rheumatology.

[16]  S. Bombardieri,et al.  Ocular involvement in giant cell arteritis. , 2013, Clinical and experimental rheumatology.

[17]  M. González-Gay,et al.  A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis. , 2013, Clinical and experimental rheumatology.

[18]  E. Abraham,et al.  Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. , 2007, Journal of immunology.

[19]  Liwu Li,et al.  Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity , 2006, Immunologic research.